Call for Papers: Special Issue on "Immuno-Oncology"

The journal Genomics, Proteomics & Bioinformatics (GPB) is interested in submissions across all areas of life science, biology, and biomedicine, focusing on leading-edge technologies and their applications in all omics studies.

Submission Deadline: May 31, 2025

Introduction | Scope | Submission | Guest editors

Introduction

GPB is inviting submissions for a special issue on the topic of “Immuno-Oncology” (to be published in the Autumn of 2025), focusing on methodological advancements, computational analyses, and data-driven discoveries in the field of immuno-oncology.

Immuno-oncology has revolutionized cancer therapy through breakthroughs in immune checkpoint inhibitors, chimeric antigen receptor (CAR)-T cell therapies, and cancer vaccines. However, further advancements require comprehensive insights into immune–tumor interactions, immune evasion mechanisms, and patient-specific responses. The integration of high-throughput omics technologies, artificial intelligence (AI), and advanced imaging techniques opens up new possibilities to unravel the complexity of immune–tumor interactions and develop personalized immunotherapies.

Scope

This special issue will highlight cutting-edge research, covering experimental methodologies, computational approaches, and translational applications in immuno-oncology.

Topics of interest include (but are not limited to):

• New experimental methodologies and technologies for immuno-oncology, including genomic, proteomic, and imaging-based approaches.
• Advances in AI and machine learning for the analysis, integration, and prediction of immuno-oncology data.
• Development and application of computational tools, workflows, databases, and visualization techniques for immuno-oncology research.
• Multi-omics and multi-modal approaches to understand tumor–immune interactions and immune evasion mechanisms.
• Large-scale data acquisition and processing for immune-related biomarker discovery and therapeutic target identification.
• Translational research and clinical applications in immuno-oncology.

Submission

Literature reviews, resource reviews, perspectives, original studies, databases, webservers, methods, application notes, protocols, etc. are all welcome. The portfolio will be open for incoming manuscripts until May 31, 2025.

Manuscripts should be prepared according to the Guide for Authors, and submitted online at https://www.editorialmanager.com/gpb/, selecting the name of the special issue "SI: Immuno-Oncology" for “Answer Required“ when providing “Additional Information” at submission.

Guest editors

Guest editors for this special issue are Dr. An-Yuan Guo (West China Hospital, Sichuan University, China), Dr Song Liu (Roswell Park Comprehensive Cancer Center, USA), Yi Xing (Children's Hospital of Philadelphia & University of Pennsylvania, USA), and Dr. Youqiong Ye (Shanghai Jiao Tong University, China).

For further information, please contact us at:

     Dr. An-Yuan Guo ([email protected]);
     Dr. Song Liu ([email protected]);
     Dr. Yi Xing ([email protected]);
     Dr. Youqiong Ye ([email protected]);
     Editorial Office ([email protected]).

An-Yuan Guo

Dr. An-Yuan Guo is a professor of the Biomedical Big Data Center, West China Hospital, Sichuan University. His research interest focuses on tumor bioinformatics, including bioinformatics methods, databases, and applications in tumor multi-omics data mining and immuno-oncology. He has developed a series of widely-used bioinformatics tools in tumor regulation, diagnosis, treatment, and prognosis, such as CM-Drug, ImmuCellAI, GSCA, AnimalTFDB, TCRdb, and TCRosetta.

[email protected]

Song Liu

Dr. Song Liu is a Professor of Oncology and Vice Chair of the Department of Biostatistics and Bioinformatics at Roswell Park Comprehensive Cancer Center. His research revolves around the development and application of computational methods to address biologically important and clinically significant questions in cancer diagnosis and treatment.

[email protected]

Yi Xing

Dr. Yi Xing is the Francis West Lewis Endowed Chair and Founding Director of the Center for Computational and Genomic Medicine, as well as the Executive Director of the Department of Biomedical and Health Informatics at the Children’s Hospital of Philadelphia (CHOP). Dr. Xing is also a Professor of Pathology and Laboratory Medicine at the University of Pennsylvania (Penn). His work has provided fundamental insights into the function, regulation, and evolution of post-transcriptional RNA processing in mammals. His current research merges the fields of computational biology, biomedical data science, RNA genomics, human genetics, precision medicine, and immuno-oncology.

[email protected]

Youqiong Ye

Dr Youqiong Ye is a PI of the Shanghai Institute of Immunology at Shanghai Jiao Tong University School of Medicine. Her lab focuses on tumor microenvironment and immunotherapy. Driven by single-cell and spatial omics, her lab develops and applies single-cell spatial omics computational methods to decode tumor spatial microenvironment, explores the molecular mechanism underlying immune escape regulated by the microenvironment in the cancer-paracancer interaction niche, and aids the development of therapeutic strategies based on tumor spatial microenvironment.

[email protected]